Psychedelic Therapy in the Treatment of Addiction

What Is Psychedelic Therapy?

Psychedelic therapy is a procedure to induce hallucinations and delusions by using a psychedelic plant to treat mental health issues, including addiction as well. The psychedelics can be classified into

• Classic Psychedelics - Classic psychedelics are also called serotonergic hallucinogens. They are psychoactive substances known for producing profound alterations in perception, mood, and cognition. Some of the most well-known classic psychedelics are lysergic acid diethylamide (LSD) psilocybin, which is found in a type of mushroom, mescaline, and Dimethyltryptamine (DMT), which is found in plants. These substances enhance sensory perception, altered sense of time, the euphoric feeling of spiritual experiences, and detailed introspection. On the other hand, it negatively impacts people by inducing anxiety, paranoia, and confusion.

• Non-Classic Psychedelic - Non-classic psychedelics, called atypical psychedelics, are a broad category of substances that are psychedelic but have different mechanisms of action than classic psychedelics. Examples are Dextromethorphan and MDMA.

What Is the Role of Psychedelic Therapy in De-addiction?

Psychedelic therapy significantly helps in addiction treatment, leveraging the unique psychoactive properties of substances like psilocybin, ibogaine, LSD, and MDMA. These therapies aim to facilitate profound psychological experiences that can positively affect behavior, cognition, and emotional regulation.

Psychedelics act by

• Neuroplasticity - Psychedelics have been found to promote neuroplasticity, which is the brain's ability to recognize itself by forming new neural connections. This is important to break the pattern of addiction.

Psilocybin and LSD increase the connectivity between different brain regions, which significantly allows individuals to break the rigid pattern of thinking and behavior that is associated with addiction.

• Consciousness - The intense experiences that are induced by psychedelics can cause a shift in perspective, which helps individuals redefine their lives and behaviors in new ways. Such experiences result in an elevated sense of meaning and purpose, reducing the existential sadness that is often the reason for addiction.

• Emotional Vent off - Psychedelics can facilitate the release of repressed emotions and provide deep insights into the psychological roots of addiction. MDMA can enhance emotional expression and empathy, allowing the person to calm the traumatic memories and mental pain that may lead to substance abuse.

• Efficacy - The studies suggest promising results. Psychedelic therapy can be more effective than traditional methods alone. However, they are considered the last option in de-addiction.

• Alignment With Psychotherapy - Psychedelic therapy is generally combined with psychotherapy. The therapeutic process involves preparation sessions, the psychedelic experience itself, and integration sessions where insights gained are processed and applied to daily life.

What Are the Applications of Various Psychedelics in De-addiction?

• Psilocybin - Psilocybin can help treat alcohol and nicotine addictions. The use of psilocybin, along with cognitive behavioral therapy, helps nearly 80 percent of cases quit smoking, which is a significantly higher rate compared to traditional treatments.

• Ibogaine - Ibogaine is a potential anti-addictive psychedelic, especially for opioid dependence. It helps by reducing withdrawal symptoms and cravings.

• LSD - LSD-assisted therapy is effective in treating alcohol addiction. It enhances psychological well-being and hence reduces the need to consume alcohol.

• MDMA - Although it has shown efficacy in cases of post-traumatic stress disorder, it can reduce addictions. Since it helps to heal from trauma and a state of despair, it automatically reduces dependence on addictive behaviors.

What Are The Challenges To Use Psychedelic Therapy?

Although psychedelic therapy has shown significant results against addiction, there are some challenges and constraints in its usage.

• Legal and Regulatory Issues - Many psychedelics are currently classified as substance abuse.

• Ethical Risk

  • Making sure that patients fully understand the potential risks and benefits of psychedelic therapy is a crucial factor. Misunderstanding can cause psychological harm.

  • The effectiveness and safety of psychedelic therapy heavily depend on the competence and ethical standards of the therapist. Inadequate training or unethical practices can cause harm to patients.

• Risk Involved

  • Psychedelics can induce intense emotional and psychological experiences, which can be overwhelming or distressing for some individuals.

  • Some individuals may experience persistent changes in perception, such as visual disturbances, after using psychedelics.

  • Psychedelics can trigger psychosis, such as schizophrenia or bipolar disorder. The risk is high for individuals with a personal or family history.

  • It can cause an increase in heart rate and blood pressure, which can be risky for individuals with cardiovascular conditions.

How Can the Risks of Psychedelic Therapy Be Managed?

The risk of psychedelics can be managed by following these strategies.

• Screening - Regular screening to identify individuals at risk for adverse reactions, such as those with a history of mental illness, is essential.

• Favorable Environment - Therapy should be conducted in a controlled, supportive environment with trained professionals who can help manage acute distress and ensure physical safety.

• Support Group - The individual seeking this therapy should have constant pre and post-therapy support.

• Regulatory Oversight - Advocacy for regulatory changes and the development of guidelines can help ensure that psychedelic therapy is conducted safely.

Conclusion

While psychedelic therapy holds a significant potential to treat various addictive conditions, it is crucial to approach it with caution, considering various challenges and legal issues. Ensuring proper screening, a controlled environment, and pre-post therapy support can help reduce the risk and maximize the potential benefits of de-addiction. As the research progresses and legal barriers are addressed, the integration of these therapies into mainstream addiction treatment can help significantly improve outcomes for many people.